HALO
Halozyme Therapeutics, Inc. · Healthcare
SVP and Chief Technical Officer Michael J. Labarre sold $1.2M of Halozyme Therapeutics, Inc.
Sold$1,228,020
$61.40Price
20,000Shares
−11%Stake
What HALO did after the filing
- The stock from Wed, Aug 21 close, $62.17
- −2.8%
- S&P 500, same days
- +1.6%
Measured over 30 trading days, to the Oct 3 close.
Traded Tue, Aug 20. Filed Wed, Aug 21, 2:03 PM ET, during the session. Returns use the Aug 21 close and the Oct 3 close. Not investment advice.